Jeffrey Farrow - Apr 24, 2023 Form 3/A - Amendment Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role: Chief Financial Officer and Chief Strategy Officer Exhibit 24 - Power of Attorney
Signature: /s/ Jeffrey Farrow
Stock symbol: TARS
Transactions as of: Apr 24, 2023
Transactions value $: $0
Form type: 3/A - Amendment
Date filed: 4/28/2023, 08:01 PM
Date Of Original Report: Apr 26, 2023
Previous filing: Oct 6, 2022
Next filing: Mar 11, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TARS	Common Stock						700	Apr 24, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock owned by the Reporting Person that were inadvertently omitted from the Reporting Person's Form 3 filed on April 26, 2023.
F2	The shares were issued pursuant to settlement of vested Restricted Stock Units previously granted under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan.

Remarks:

Chief Financial Officer and Chief Strategy Officer Exhibit 24 - Power of Attorney